United States· US:64764-140_758b0d1f-9d6c-42f9-a23b-6f75e9181842
ADZYNMA
A medicinal product, registered in United States by TAKEDA PHARMACEUTICALS AMERICA, INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Manufacturer
- TAKEDA PHARMACEUTICALS AMERICA, INC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1164764-140-05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6e2154f-d347-40ca-a1ec-8423daac6811 GET /v1/drugs/b6e2154f-d347-40ca-a1ec-8423daac6811?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": null,
"source": "ndc",
"strength": null,
"substance": null,
"productndc": "64764-140",
"dosage_form": "KIT",
"dea_schedule": null,
"strength_unit": null,
"application_number": "BLA125795",
"marketing_category": "BLA"
}See everything about ADZYNMA.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.